140 related articles for article (PubMed ID: 21645920)
1. Self-protecting core-shell magnetic nanoparticles for targeted, traceable, long half-life delivery of BCNU to gliomas.
Yang HW; Hua MY; Liu HL; Huang CY; Tsai RY; Lu YJ; Chen JY; Tang HJ; Hsien HY; Chang YS; Yen TC; Chen PY; Wei KC
Biomaterials; 2011 Sep; 32(27):6523-32. PubMed ID: 21645920
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of a magnetic nanoparticle-based delivery system for BCNU in the treatment of gliomas.
Hua MY; Liu HL; Yang HW; Chen PY; Tsai RY; Huang CY; Tseng IC; Lyu LA; Ma CC; Tang HJ; Yen TC; Wei KC
Biomaterials; 2011 Jan; 32(2):516-27. PubMed ID: 21030073
[TBL] [Abstract][Full Text] [Related]
3. Improving thermal stability and efficacy of BCNU in treating glioma cells using PAA-functionalized graphene oxide.
Lu YJ; Yang HW; Hung SC; Huang CY; Li SM; Ma CC; Chen PY; Tsai HC; Wei KC; Chen JP
Int J Nanomedicine; 2012; 7():1737-47. PubMed ID: 22619524
[TBL] [Abstract][Full Text] [Related]
4. AN in vitro evaluation of a carmustine-loaded Nano-co-Plex for potential magnetic-targeted intranasal delivery to the brain.
Akilo OD; Choonara YE; Strydom AM; du Toit LC; Kumar P; Modi G; Pillay V
Int J Pharm; 2016 Mar; 500(1-2):196-209. PubMed ID: 26806465
[TBL] [Abstract][Full Text] [Related]
5. Cationic core-shell nanoparticles with carmustine contained within O⁶-benzylguanine shell for glioma therapy.
Qian L; Zheng J; Wang K; Tang Y; Zhang X; Zhang H; Huang F; Pei Y; Jiang Y
Biomaterials; 2013 Nov; 34(35):8968-78. PubMed ID: 23953782
[TBL] [Abstract][Full Text] [Related]
6. Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment.
Ting CY; Fan CH; Liu HL; Huang CY; Hsieh HY; Yen TC; Wei KC; Yeh CK
Biomaterials; 2012 Jan; 33(2):704-12. PubMed ID: 22019122
[TBL] [Abstract][Full Text] [Related]
7. Resorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank model.
Kim GY; Tyler BM; Tupper MM; Karp JM; Langer RS; Brem H; Cima MJ
J Control Release; 2007 Nov; 123(2):172-8. PubMed ID: 17884232
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic expression of O(6)-methylguanine DNA methyltransferase-P140K allows intensive treatment of human glioma xenografts with combination O(6)-benzylguanine and 1,3-bis-(2-chloroethyl)-1-nitrosourea.
Kreklau EL; Pollok KE; Bailey BJ; Liu N; Hartwell JR; Williams DA; Erickson LC
Mol Cancer Ther; 2003 Dec; 2(12):1321-9. PubMed ID: 14707273
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of C6 glioma in vivo by combination chemotherapy of implantation of polymer wafer and intracarotid perfusion of transferrin-decorated nanoparticles.
Han L; Ren Y; Long L; Zhong Y; Shen C; Pu P; Yuan X; Kang C
Oncol Rep; 2012 Jan; 27(1):121-8. PubMed ID: 21922149
[TBL] [Abstract][Full Text] [Related]
10. 1,3-Bis(2-chloroethyl)-1-nitrosourea-loaded bovine serum albumin nanoparticles with dual magnetic resonance-fluorescence imaging for tracking of chemotherapeutic agents.
Wei KC; Lin FW; Huang CY; Ma CC; Chen JY; Feng LY; Yang HW
Int J Nanomedicine; 2016; 11():4065-75. PubMed ID: 27601895
[TBL] [Abstract][Full Text] [Related]
11. Development and in vitro evaluation of carmustine delivery platform: A hypoxia-sensitive anti-drug resistant nanomicelle with BBB penetrating ability.
Li D; Ren T; Wang X; Xiao Z; Sun G; Zhang N; Zhao L; Zhong R
Biomed Pharmacother; 2023 Nov; 167():115631. PubMed ID: 37804814
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of bcl-2 and cox-2 Protein Expression after Local Application of a New Carmustine-Loaded Clinoptilolite-Based Delivery System in a Chemically Induced Skin Cancer Model in Mice.
Ghiciuc CM; Strat AL; Ochiuz L; Lupusoru CE; Ignat M; Vasile A; Grigorovici A; Stoleriu I; Solcan C
Molecules; 2017 Nov; 22(11):. PubMed ID: 29156646
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of the stability of BCNU using self-emulsifying drug delivery systems (SEDDS) and in vitro antitumor activity of self-emulsified BCNU-loaded PLGA wafer.
Chae GS; Lee JS; Kim SH; Seo KS; Kim MS; Lee HB; Khang G
Int J Pharm; 2005 Sep; 301(1-2):6-14. PubMed ID: 16024190
[TBL] [Abstract][Full Text] [Related]
14. O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma.
Rhines LD; Sampath P; Dolan ME; Tyler BM; Brem H; Weingart J
Cancer Res; 2000 Nov; 60(22):6307-10. PubMed ID: 11103789
[TBL] [Abstract][Full Text] [Related]
15. Superhigh-magnetization nanocarrier as a doxorubicin delivery platform for magnetic targeting therapy.
Hua MY; Yang HW; Liu HL; Tsai RY; Pang ST; Chuang KL; Chang YS; Hwang TL; Chang YH; Chuang HC; Chuang CK
Biomaterials; 2011 Dec; 32(34):8999-9010. PubMed ID: 21872924
[TBL] [Abstract][Full Text] [Related]
16. Predicting and monitoring response to chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea in subcutaneously implanted 9L glioma using the apparent diffusion coefficient of water and 23Na MRI.
Babsky AM; Hekmatyar SK; Zhang H; Solomon JL; Bansal N
J Magn Reson Imaging; 2006 Jul; 24(1):132-9. PubMed ID: 16758478
[TBL] [Abstract][Full Text] [Related]
17. Design and construction of multifunctional hyperbranched polymers coated magnetite nanoparticles for both targeting magnetic resonance imaging and cancer therapy.
Mashhadi Malekzadeh A; Ramazani A; Tabatabaei Rezaei SJ; Niknejad H
J Colloid Interface Sci; 2017 Mar; 490():64-73. PubMed ID: 27870961
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study.
Kitamura I; Kochi M; Matsumoto Y; Ueoka R; Kuratsu J; Ushio Y
Cancer Res; 1996 Sep; 56(17):3986-92. PubMed ID: 8752168
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antitumor activity of sarCNU in comparison to BCNU in an extraneuronal monoamine transporter positive human glioma xenograft model.
Chen ZP; Wang G; Huang Q; Sun ZF; Zhou LY; Wang AD; Panasci LC
J Neurooncol; 1999 Aug; 44(1):7-14. PubMed ID: 10582663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
